AstraZeneca has announced a fresh shortfall in planned vaccine shipments to the European Union, citing production problems and export restrictions.
“AstraZeneca is disappointed to announce a shortfall in planned Covid-19 vaccine shipments to the European Union (EU) despite working tirelessly to accelerate supply,” it said in a statement.
The company had previously warned it was facing shortfalls from its European supply chain due to “lower-than-expected output from the production process.”
“Unfortunately, export restrictions will reduce deliveries in the first quarter, and are likely to affect deliveries in the second quarter,” it added.
The relationship between AstraZeneca and the EU and member states has been uneasy in recent months. This new upset is likely to further dampen relations.